The mean conjunctival inflammatory cell densities in the SSDE, NSSDE, and healthy control eyes were 433 ± 435.8, 134.8 ± 124.2, and 10 ± 17.9 cells/mm
2, respectively. The differences were statistically significant, as shown in
Figure 1 (
P < 0.001). The mean corneal inflammatory cell densities in the SSDE, NSSDE, and healthy control eyes were 45.5 ± 38.5, 22.2 ± 25.1, and 2.23 ± 8.5 cells/mm
2, respectively (
Fig. 1). The statistical significances are shown in
Figure 1. In all the SSDE eyes, in vivo confocal microscopy consistently displayed inflammatory infiltrates within the epithelium, mainly consisting of polymorphs, dendritic cells, and/or lymphocytes.
Figures 2A and
2B display representative in vivo confocal scans from a patient with SSDE and an age- and sex-matched healthy control subject, respectively. Confocal microscopy images from the patients with SSDE who consented to additional examinations after 1 month of follow-up demonstrated extensive inflammation consisting of polymorphs, dendritic cells, and/or lymphocytes within the conjunctival epithelium before treatment.
Figures 3A–C show representative confocal scans from a 52-year-old woman with SSDE. After 1 month of dry eye treatment, considerable reduction of conjunctival inflammatory infiltrates at two conjunctival epithelial depths (65 and 75 μm) were observed (
Figs. 3B–D). Pretreatment inflammatory infiltrates mainly consisted of polymorphs and dendritic cells.
Figures 4A and
4B show representative in vivo confocal microscopy scans and anterior segment photographs of the ocular surface in a 54-year-old woman with SSDE. After 1 month of treatment, a considerable decrease in the inflammatory cell density was observed (
Figs. 4A1,
4B1). Fluorescein staining scores decreased from 5 points to 1 point (
Figs. 4A2,
4B2) and rose bengal staining scores changed from 5 to 3 points. (
Figs. 4A3,
4B3) The pretreatment BUT value was 3 seconds and increased to 5 seconds after 1 month of treatment.